Zhang et al. [23] have reported that silencing AURKA enhanced the sensitivity of HCC cells to chemotherapeutic agents doxorubicin and cisplatin, whereas AURKA overexpression reduced the HCC human cellular response to chemotherapy-induced apoptosis. The gene discussed is AURKA; the disease is hepatocellular carcinoma.